Documentos de Académico
Documentos de Profesional
Documentos de Cultura
PRECOCIOUS
PRECOCIOUSPUBERTY
PUBERTY
INTRODUCTION
Epidemiology
Age of onset
between 7-7.9 year olds
6 year olds
< 6 years old.
59.6%
22.4%
18%
Etiology
Gonadotropin Dependent
Gonadotropin independent
97.7%
2.3%
Neurogenic abnormalities
(MR/CT skull)
18.4%
Precocious Puberty
Definition
Appearance of
secondary sexual
characteristics : boys <
9 years and girls < 8
years old (- 2SD)
Sex steroid
Estrogen: female
Testosterone:male
Classification
GnRH dependent (central) :
premature reactivation hypothalamus-pituitarygonad axis increased gonadotropin
increased sex steroids (dependent)
Usually idiopathic
GnRH independent (peripheral):
autonomous sex steroid secretion,
depressing the hypothalamus-pituitary-gonad
axis
Usually pathologic
Classification
Variant
premature thelarche
premature adrenarche
gynecomastia
Etiology GDPP
idiopathic
CNS
tumor
non-tumor: post infection, radiation,
trauma, congenital
iatrogenic
Delayed diagnosis of GIPP
Premature Adrenarche
Excude virilization
clitoral enlargement, advanced bone
age, acne, rapid growth, and voice
change.
rapid progression
If virilization present
measure testosterone, 17-OHP and
DHEA
USG: adrenal or ovarian tumor
17-OHP or DHEA: CAH
Gynecomastia
Breast enlargement in males
common in teenage years, lasting 2 years
differentiate with obese boys
lipomastia
no mammae disk
Pathological causes must be sought
Pubertal Gynecomastia
Incidence: 50-60% of boys during early
adolescence
breast tissue usually asymmetric and often
tender.
If history and physical examination,
including palpation of the testicles, are
unremarkable, reassurance and periodic
reevaluation are all that is necessary. Most
cases resolve in one to two years.
Gynecomastia
Drugs
sex steroids, hCG,
psychoactive (phenotiazine),
antituberculosis,
testosterone antagonist
(ketoconazole, cimetidine,
spironolactone)
Malnutrition
Idiopathic (most common)
Tumor producing disease
hepatoma, adrenal, testes, LH
and hCG producing tumors
Pubertal Gynecomastia
Familial gynecomastia
X-linked recessive trait or a sex-limited
dominant trait
unless associated with hypogonadism no
further evaluation in an otherwise normal boy
If severe, gynecomastia cosmetic surgery.
Pathologic gynecomastia
Klinefelter's syndrome: high risk for breast
cancer
prolactin-secreting adenomata
Pubertal Gynecomastia
Pathologic gynecomastia
hormone-secreting tumors (testes,
hepatoma), cirrhosis, hypo- and
hyperthyroidism.
Drug induced (marijuana, phenothiazines,
opiates, amphetamines, digitalis, estrogens,
ketoconazole, spironolactone, isoniazid,
tricyclic antidepressants, cimetidine, etc).
If worsens and associated with psychologic
morbidity bromocriptine, tamoxifen
reduction mammoplasty rarely indicated .
Diagnostic work up
Gonadotropin dependent or independent?
Etiology?
Hypothalamu
Hypothalamu
ss
GnRH
(-)
Pituitar
Pituitar
yy
LH/FSH
Gonad
Gonad
E2 or T
H-P-G
H-P-G axis
axis
Hypothalam
Hypothalam
us
us
GnRH
(-)
Pituitar
Pituitar
yy
LH/FSH
Gonad
Gonad
Sex steroid
H-P-G
H-P-G axis
axis in
in GDPP
GDPP
Primary
Hypothalamu
Hypothalamu
ss
GnRH
Pituitar
Pituitar
yy
LH/FSH
(-)
Gonad
Gonad
IM
R
P
Extra Gonadal
Gonadal
Extra
Y
R
A
Sex steroid
H-P-G axis in GIPP
Diagnostic work up
History
age of onset, progressivity, family history,
growth, symptoms extragonadal cause
(adrenal), CNS complaints, gelactic laughter
(hamartoma), previous history: encephalitis,
meningitis TB
Physical examination
pubertal stage, signs of virilisation, height,
testes size (small indicative of perpheral
cause), CNS signs, skin (acne, caf au lait),
Diagnostic work up
Laboratory
gonadotropin, HCG, 17-OHProgesterone
(CAH), cortisol (Cushing syndrome,
adrenal tumor)
Imaging
Bone age, pelvic ultrasound, skull x-ray,
CT/MRI, bone survey (McCune Albright),
Therapy
According to the etiology
GDPP idiopathic: GnRH agonis
GIPP : medroxy-progesteron,
ketoconazole, dll
Variant: observation
Prognosis
According to etiology
GDPP idiopathic: GnRH agonis
Final height = potential genetic height
Preserved fertility
Psychosocial minimal, regression of
secondary sex
GIPP : medical
Potential genetic height
Regression of secondary sex
Conclusion
Not all pubertal disorders are pathologic
Early increase of sex steroid should be
thoroughly investigated
GnRH agonist = drug of choice for
GDPP
DELAYED PUBERTY
Definisi
Pubertas terlambat bila tidak adanya
tanda-tanda pubertas
laki-laki pada usia 14 tahun
perempuan pada usia 13 tahun
Klasifikasi
hipergonadotropik hipogonadism
hipogonadotropik hipogonadism
Ammenorrhoe primer
Ammenorrhoe sekunder
Hipergonadotropik hipogonadism
Hipotalamus
Hipofisis
LHRH
LH/FSH
(-)
Target Organ
(gonad)
Primary defect
Sex Steroid
Hipergonadotropik hipogonadism
Dengan kelainan kromosom
Dysgenesis gonad
Sindrom Turner
Pure gonadal dysgenesis
Sindrom Klinefelter
Androgen Insensitivity Syndrome *
Hipergonadotropik hipogonadism
Tanpa kelainan kromosom
kongenital
gangguan biosintesis steroid adrenal
(P450c17,P450scc,3HSD) dan
gonad (17-KS, P450 aromatase)
anorchia, ovary resistant syndrome,
LH resistance
didapat
radiasi, chemotherapy, proses
autoimun
Hipogonadotropik hipogonadism
Hipotalamus
LHRH
Primary defect
Hipofisis
LH/FSH
(-)
Target Organ
(gonad)
Sex Steroid
Hipogonadotropik hipogonadism
Constitutional delay
Kelainan Susunan Syaraf Pusat
Tumor (craniopharyngioma, germinoma,
optic glioma, histiocytosis X)
Struktural (mid line defect)
Sindrom Kallmann
hipopituitarism idiopathic
pasca tindakan (radiasi, khemoterapi
inflamasi, infiltrasi - hemosiderosis)
Hipogonadotropik hipogonadism
Penyakit kronis
endokrin, malnutrisi/anorexia nervosa,
kelainan sistemik
Aktivitas fisik berlebihan
Sindrom-sindrom
Prader-Willi; Laurence-Moon-Biedl
Puberty failure:
males 41 %
females 39,5 %
All patient with hemachromatosis need
periodic careful endocrine evaluation
Tatalaksana
Anamnesis
Pemeriksaan fisik
Pemeriksaan penunjang
Terapi
Anamnesis
Riwayat perkembangan pubertas di dalam
keluarga
Data pertumbuhan & perkembangan
Riwayat penyakit/pengobatan dahulu
Fungsi penciuman
Pemeriksaan fisik
Pemeriksaan fisik secara umum
Pemeriksaan neurologis (funduskopi) d
Antropometri (TB, BB, rasio segmen atas
dan bawah, rentang lengan)
Status pubertas
Stigmata suatu sindrom (pendek, obese,
retardasi mental, webbed neck dll)
Pemeriksaan Penunjang
Pencitraan:
usia tulang, CT scan/MRI kepala & USG
genitalia interna (atas indikasi),
Dan lain-lain
analisis kromosom (atas indikasi)
uji fungsi penciuman
Pubertal
Pubertal Delay
Delay
Any
Anysigns
signsof
ofpuberty?
puberty?
YES
YES
Psychological
Psychologicaldistress?
distress?
NO
NO
NO
NO
Check
Check
height,
height, FSH/LH,
FSH/LH,TT4/TSH,
4/TSH,
Prolactin,
Prolactin,Karyotype
Karyotype(girls)
(girls)
YES
YES
Low
LowFSH/LH
FSH/LH
High
HighFSH
FSH
GnRh
GnRh/ /
sex
sexsteroids
steroids
sex
sexsteroids
steroids
oxandrolone
oxandrolone/ /
sex
sexsteroids
steroids
Monitor
Monitorgrowth
growth&&pubertal
pubertal
progress
progress
Hormonal replacement
Discrepancies exist concerning
the age of initiation
dosage
Hormonal replacement
Females :
start estrogen 0,25 mg daily (6-9
months)
after 9 MOs cyclic therapy estrogen
for 1st 21 days
Males:
testosterone enanthate 50 mg IM/
monthly
after 6-9 MOs, dose gradually increased
to 200 mg/3 weeks (2-3 years)
KESIMPULAN
Pubertas berlangsung menurut stadium,
umur tertentu
Pubertas harus selalu menjadi perhatian
orangtua / tenaga kesehatan
Setiap tenaga kesehatan dapat
mendeteksi kelainan pubertas secara
dini dan segera melakukan rujukan